Modified photosynthetic microorganisms for producing lipids
This disclosure describes genetically modified photosynthetic microorganisms, e.g., Cyanobacteria, that overexpress an acyl carrier protein (ACP), an acyl-ACP synthase (Aas), or both, optionally in combination with one or more overexpressed or exogenous lipid biosynthesis proteins, and/or one or more overexpressed or exogenous glycogen breakdown proteins. Exemplary biosynthesis proteins include diacyglycerol acyltransferases, thioesterases, phosphatidate phosphatases, phospholipases, triacylglycerol (TAG) hydrolases, fatty acyl-CoA synthetases, and/or acetyl-CoA carboxylases, including combinations thereof. Also included are photosynthetic microorganisms comprising mutations or deletions in a glycogen biosynthesis or storage pathway, which accumulate a reduced amount of glycogen under reduced nitrogen conditions as compared to a wild type photosynthetic microorganism. The modified photosynthetic microorganisms provided herein are capable of producing increased amounts of lipids such as fatty acids and/or synthesizing triglycerides.
1. A modified Cyanobacterium comprising:
(i) a first modification that increases acyl-ACP synthesis in the modified Cyanobacterium, the first modification comprising an introduced polynucleotide encoding an acyl carrier protein (ACP); and
(ii) a second modification that increases a lipid biosynthesis protein in the modified Cyanobacterium, the second modification comprising an introduced polynucleotide encoding a lipid biosynthesis protein,
wherein said modified Cyanobacterium produces an increased amount of lipid as compared to a corresponding wild-type Cyanobacterium, a corresponding Cyanobacterium having only the first modification, or a corresponding Cyanobacterium having only the second modification.
2. The modified Cyanobacterium of claim 1 , wherein the lipid biosynthesis protein is selected from the group consisting of an acyl-ACP thioesterase (TES), a diacylglycerol acyltransferase (DGAT), an acetyl coenzyme A carboxylase (ACCase), a phosphatidic acid phosphatase (PAP), a triacylglycerol (TAG) hydrolase, a fatty acyl-CoA synthetase, a phospholipase (PL), and combinations thereof.
3. The modified Cyanobacterium of claim 2 , wherein the lipid biosynthesis protein is selected from the group consisting of TES and DGAT.
4. The modified Cyanobacterium of claim 3 , wherein the TES is a TesA, a TesB, or a FatB thioesterase, and the DGAT is a prokaryotic DGAT that uses acyl-ACP as a substrate.
5. The modified Cyanobacterium of claim 1 , further comprising a third modification that reduces glycogen accumulation in the modified Cyanobacterium, the third modification comprises (i) a full or partial deletion of a gene of a glycogen biosynthesis pathway or a glycogen storage pathway or (ii) reduced expression of a gene of a glycogen biosynthesis pathway or a glycogen storage pathway as compared to the corresponding wild-type Cyanobacterium.
6. The modified Cyanobacterium of claim 5 , wherein the gene is selected from a glucose-1-phosphate adenyltransferase (glgC) gene and a phosphoglucomutase (pgm) gene.
7. The modified Cyanobacterium of claim 1 , further comprising a third modification that reduces glycogen accumulation in the modified Cyanobacterium, the third modification comprises an introduced polynucleotide encoding a protein of a glycogen breakdown pathway or an overexpressed glycogen breakdown pathway gene.
8. The modified Cyanobacterium of claim 1 , wherein said Cyanobacterium is an Arthrospira ; a Synechococcus elongatus sp. PCC 7942; a salt tolerant variant of Synechococcus elongatus sp. PCC 7942; a Synechococcus elongatus sp. PCC 7002; or a Synechocystis elongatus sp. PCC 6803.
9. A method of producing a modified Cyanobacterium that produces or accumulates an increased amount of lipid as compared to a corresponding wild-type Cyanobacterium, comprising
(i) making a first modification that increases acyl-ACP synthesis in the modified Cyanobacterium, the first modification comprising introducing a polynucleotide encoding an acyl carrier protein (ACP); and
(ii) making a second modification that increases a lipid biosynthesis protein in the modified Cyanobacterium, the second modification comprising introducing a polynucleotide encoding a lipid biosynthesis protein.
10. The method of claim 9 , wherein the lipid biosynthesis protein is-selected from the group consisting of an acyl-ACP thioesterase (TES), a diacylglycerol acyltransferase (DGAT), an acetyl coenzyme A carboxylase (ACCase), a phosphatidic acid phosphatase (PAP), a triacylglycerol (TAG) hydrolase, a fatty acyl-CoA synthetase, a phospholipase (PL), and combinations thereof.
11. The method of claim 10 , wherein the lipid biosynthesis protein is selected from the group consisting of TES and DGAT, said TES is a TesA, a TesB, or a FatB thioesterase, and said DGAT is a prokaryotic DGAT that uses acyl-ACP as a substrate.
12. The method of claim 9 , further comprising making a third modification that reduces glycogen accumulation in the modified Cyanobacterium, the third modification comprising deleting, fully or partially, a gene of a glycogen biosynthesis pathway or a glycogen storage pathway.
13. The method of claim 12 , wherein the gene is selected from a glucose-1-phosphate adenyltransferase (glgC) gene and a phosphoglucomutase (pgm) gene.
14. The method of claim 9 , further comprising making a third modification that reduces glycogen accumulation in the modified Cyanobacterium, the third modification comprising introducing a polynucleotide encoding a protein of a glycogen breakdown pathway or overexpressing a glycogen breakdown pathway gene.
15. The method of claim 9 wherein said Cyanobacterium is an Arthrospira ; a Synechococcus elongatus sp. PCC 7942; a salt tolerant variant of Synechococcus elongatus sp. PCC 7942; a Synechococcus elongatus sp. PCC 7002; or a Synechocystis elongatus sp. PCC 6803.
16. A method for producing lipids, comprising culturing the modified Cyanobacterium according to claim 1 .
17. The method according to claim 16 , wherein said lipids comprise a triglyceride, a free fatty acid, or both.
18. The method of claim 9 , wherein making the first modification further comprises introducing a polynucleotide encoding an acyl-ACP synthetase (Aas).
19. The modified Cyanobacterium of claim 1 , wherein the first modification further comprises an introduced polynucleotide encoding an acyl-ACP synthetase (Aas).
20. The modified Cyanobacterium of claim 19 , wherein:
the ACP is a bacterial or a plant ACP, or
the Aas is a bacterial Aas.